Found 86 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
68Ga-DOTATATE Neuroblastoma Imaging Pilot PHASE2 Neuroblastoma is the most frequent extracranial childhood tumor, with an an...
Show More Location
McGill University Health Center - Children's hospital
Learn More & Join Trial
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors. N/A Neuroendocrine tumors (NETs) constitute approximately 0.5% of malignancies....
Show More Location
Irccs San Raffaele
Learn More & Join Trial
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors NA This is a research study to collect information regarding usefulness of pos...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors EARLY_PHASE1 This trial studies how well an investigational scan called 68Ga-DOTATATE PE...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging N/A Quantitative parameters obtained with dynamic whole body imaging using posi...
Show More Learn More & Join Trial
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer PHASE2 Background:
About 5% to 10% of differentiated thyroid cancers become resis...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Molecular Imaging in Fabry Disease of the Heart N/A Better methods for early detection of cardiac involvement in Fabry disease ...
Show More Location
Cambridge University Hospital NHS Foundation Trust
Learn More & Join Trial
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) PHASE2 This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors PHASE3 This is a single-arm imaging study using DOTATOC peptide, labelled with the...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial